ORG Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
250
+37
| +17% | +$16.7K | 0.02% | 410 |
|
|
2025
Q1 | $103K | Buy |
213
+111
| +109% | +$53.8K | 0.03% | 380 |
|
|
2024
Q4 | $41.1K | Buy |
102
+53
| +108% | +$21.3K | 0.01% | 603 |
|
|
2024
Q3 | $22.8K | Sell |
49
-3
| -6% | -$1.4K | ﹤0.01% | 652 |
|
|
2024
Q2 | $24.5K | Buy |
52
+44
| +550% | +$20.7K | ﹤0.01% | 1011 |
|
|
2024
Q1 | $3.36K | Sell |
8
-7
| -47% | -$2.94K | 0.01% | 372 |
|
|
2023
Q4 | $6.1K | Sell |
15
-42
| -74% | -$17.1K | ﹤0.01% | 819 |
|
|
2023
Q3 | $19.8K | Sell |
57
-4
| -7% | -$1.39K | 0.01% | 698 |
|
|
2023
Q2 | $21.3K | Buy |
+61
| New | +$21.3K | ﹤0.01% | 859 |
|